Rhythm Pharmaceuticals, Inc.
RYTM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$261 | -$185 | -$181 | -$70 |
| Dep. & Amort. | $2 | $2 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$100 |
| Stock-Based Comp. | $40 | $33 | $20 | $21 |
| Change in WC | $11 | $5 | -$20 | $2 |
| Other Non-Cash | $95 | $9 | $6 | -$0 |
| Operating Cash Flow | -$114 | -$136 | -$173 | -$146 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$4 | -$5 |
| Net Acquisitions | $0 | $0 | $4 | $100 |
| Inv. Purchases | -$268 | -$355 | -$252 | -$525 |
| Inv. Sales/Matur. | $261 | $355 | $284 | $361 |
| Other Inv. Act. | -$41 | -$6 | -$4 | $7 |
| Investing Cash Flow | -$48 | -$6 | $28 | -$62 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$13 | $0 | $0 | $0 |
| Stock Issued | $195 | $49 | $131 | $162 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$4 | $0 | $0 | $0 |
| Other Fin. Act. | $13 | $25 | $83 | $5 |
| Financing Cash Flow | $191 | $74 | $214 | $166 |
| Forex Effect | $0 | -$0 | $0 | $0 |
| Net Chg. in Cash | $29 | -$68 | $68 | -$42 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60 | $128 | $60 | $101 |
| End Cash | $90 | $60 | $128 | $60 |
| Free Cash Flow | -$114 | -$136 | -$178 | -$151 |